Navigation Links
GlaxoSmithKline Share Their Insight on Understanding DDI With a View to Better Prediction and Control
Date:6/28/2012

LONDON, June 28, 2012 /PRNewswire/ --

Pharma IQ has released a new interview with Dr. James Clarke, Senior Scientist, GlaxoSmithKline, on the biggest challenges for clinically relevant drug transporters that GSK faces.

In this exclusive podcast Dr. Clarke shares his knowledge on how drug transporters exert a vital influence on drug absorption, disposition, metabolism and elimination and why they are an essential part of predicting drug disposition. He provides ideas on how the current technology landscape changed following the publication of the ITC white paper and the progress we can expect to see in clinically relevant drug transporters.

This interview was created as a part of the pre-conference research for the 3rd Annual Clinically Relevant Drug Transporters, taking place from the 22nd- 24th  October, 2012 in London.

The interview helped to shape the summit agenda which features among others - Eva Gil Berglund, PhD, Medical Products Agency, Sweden and Keith Hoffmaster, Senior Investigator from Novartis (ITC member) who provide an insight into new developments in the FDA / EMA transporter interaction Draft Guidance Papers.

Other important topics which will be discussed at the event include:

  • Model-based Prediction of Transporter-mediated Disposition and DDIs (Manthena Varma, Principle Scientist, Pfizer)
  • Drug Targeting: how can we use Uptake Transporters to achieve CNS or Tumour Penetration  (Maarten Huisman, Janssen Pharmaceutical Companies)
  • De-risking conjugated metabolites for causing transporter DDI with toxicological implications (Timothy Shultz - Utermoehl, Shire Pharmaceuticals)
  • Impact of "transporter-metabolism" and "transporter-transporter" interplay in Raloxifene Disposition (Jae Chang, Research Scientist, Genentech)

Press are invited to attend this important industry forum. If you would like to a complimentary press pass please email Joanna Checinska (joanna.checinska@iqpc.co.uk)

To access Dr. James Clarke's full interview or find out more about the Clinically Relevant Drug Transporters Summit please visit http://www.drugrtransporters/news, email enquire@iqpc.co.uk or call +44(0)207-930-1300.

Media contact: Joanna Checinska, +44(0)20-7368-9807, joanna.checinska@iqpc.co.uk  - Please contact for more information or images.


'/>"/>
SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Employees Embark on Long-Term Volunteer Assignments throughout the World
2. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
3. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
4. Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
5. Heska Announces Quarterly Dividend of $0.10 Per Share
6. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
7. OncoSec Medical Issues Letter to Shareholders
8. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
9. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
10. Omnyx Share Their Insight on Agile Software Development for Medical Devices
11. Faruqi & Faruqi, LLP is Investigating Pain Therapeutics Inc. on Behalf of its Shareholders (PTIE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading ... today announced that Kyle Allain has joined the company as Vice President and ... operations, including provider, payor and managed care solutions. , A seasoned executive ...
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health ... anxiety levels in people with addiction who are served by MAP’s patient engagement ... wearable device that monitors heart and breath rates to identify anxiety levels and ...
(Date:4/24/2017)... ... ... As a former supermodel known for her timeless beauty, Joan Severance knows ... is that she put all the words in her new book, "Manifest Your Mate: ... and sparkling sense of humor have inspired her to write a book on how ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Donna Parker, L. ... she has not found any of them to be very practical. She wanted to ... and easily make changes in their health. It prompted her in writing “ A ...
(Date:4/24/2017)... , ... April 24, 2017 , ... “Learning to Use ... navigate life. “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is ... various nonprofits, former Chairman of the Board of Directors for CONTACT USA, and former ...
Breaking Medicine News(10 mins):